Table 2.
Changes in AST, GPT, ALP, and W/D.
Group | AST (U/L) | W/D | ALP (U/L) | GPT (U/L) |
---|---|---|---|---|
Control | 153.2 ± 6.3 | 3.6 ± 0.2 | 89.8 ± 5.2 | 42.3 ± 5.6 |
Mimics | 296.8 ± 2.8∗ | 10.2 ± 1.3∗ | 205.5 ± 4.4∗ | 127.1 ± 5.7∗ |
Inhibitors | 183.6 ± 3.5# | 5.3 ± 1.9# | 101.1 ± 5.8# | 50.7 ± 4.5# |
Note: the content of AST, GPT, and ALP and pulmonary tissue W/D decline markedly in the inhibitors group, while they are notably elevated in the mimics group (p < 0.05). ∗p < 0.05 vs. the control group, #p < 0.05 vs. the mimics group.